Literature DB >> 7082543

Saliva concentrations of lignocaine in healthy volunteers.

J Kanto, R Sellman, E Laurikainen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7082543      PMCID： PMC1402095          DOI： 10.1111/j.1365-2125.1982.tb01447.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of local anaesthetics.

Authors:  G T Tucker; L E Mather
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

Review 3.  Measurement of drugs in saliva: a review.

Authors:  J W Paxton
Journal:  Methods Find Exp Clin Pharmacol       Date:  1979-04

4.  Determination of lidocaine in blood and tissues.

Authors:  N Benowitz; M Rowland
Journal:  Anesthesiology       Date:  1973-12       Impact factor: 7.892

Review 5.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447
  5 in total
  3 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  Saliva concentrations of lignocaine in patients with acute myocardial ischaemia.

Authors:  E Laurikainen; J Kanto
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

3.  Pharmacokinetics of single-dose primaquine in patients with chronic kidney dysfunction.

Authors:  Shaunak P Kulkarni; Sanjana R Shah; Prashant P Kadam; Kannan Sridharan; Nivrutti K Hase; Partha P Shetty; Urmila M Thatte; Nithya J Gogtay
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.